Ameriprise Financial Inc Senseonics Holdings, Inc. Transaction History

Ameriprise Financial Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.7 $1,344 - $1,959	-2,800 Reduced 18.92%	12,000 $6,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.89 $12,267 - $19,851	-22,305 Reduced 60.11%	14,800 $11,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $13 - $25	-20 Reduced 0.05%	37,105 $26,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.34 $1,953 - $2,726	-2,035 Reduced 5.2%	37,125 $38,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $22,751 - $49,740	22,305 Added 132.33%	39,160 $52,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.94 $739 - $1,526	-787 Reduced 4.46%	16,855 $17,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $3,834 - $9,237	2,490 Added 16.43%	17,642 $35,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $4,971 - $7,534	-1,927 Reduced 11.28%	15,152 $41,000
Q3 2021 Nov 15, 2021	BUY	$2.77 - $4.05 $14,068 - $20,569	5,079 Added 42.33%	17,079 $58,000
Q1 2021 May 17, 2021	SELL	$0.85 - $5.27 $3,570 - $22,134	-4,200 Reduced 25.93%	12,000 $32,000
Q3 2020 Nov 16, 2020	BUY	$0.36 - $0.53 $5,832 - $8,586	16,200 New	16,200 $6,000
Q2 2019 Aug 14, 2019	SELL	$1.81 - $2.45 $50,381 - $68,195	-27,835 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.3 - $3.27 $64,020 - $91,020	27,835 New	27,835 $68,000

136

60.1M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $475M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.